Home/Database/Mecasermin
Growth HormoneClinical/Approved

Mecasermin

Recombinant human insulin-like growth factor-1 (rhIGF-1)

70 Amino Acids · MW: 7649 Da

Amino Acids

70

Molecular Weight

7649 Da

Half-life

6 hours

Research Score

4.5

Studies

180

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is Mecasermin?

Mecasermin is recombinant human IGF-1, used to bypass deficient GH signaling when endogenous IGF-1 production is inadequate. It acts downstream of growth hormone and directly activates IGF-1 receptors in target tissues.

Key Benefits & Mechanisms

linear growth in IGF-1 deficiency

direct IGF-1 receptor activation

anabolic signaling

tissue growth support

Research Summary

Mecasermin has substantial clinical literature in severe primary IGF-1 deficiency and related growth disorders. Research emphasizes its ability to increase growth in patients who do not respond adequately to GH alone, but its use is constrained by hypoglycemia risk.